Company intelligence
Pelthos Therapeutics
Innovative therapies for patients with unmet needs.
Pharmaceutical Manufacturing
Durham, US
105 employees
Founded 2024
2 public signals
About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative therapeutic products for high unmet patient needs. The company’s lead product is ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of Molluscum contagiosum.
Verified activity
Signals from Pelthos Therapeutics
2 published signals
Research & Knowledge
Pelthos Therapeutics published a story in Innovate Carolina detailing the scientific discovery that began at The University of North Carolina at Chapel Hill and led to the development of berdazimer gel 10.3%
Reported by Pelthos Therapeutics
Presence & Recognition
Pelthos Therapeutics attended the LEADderm 2026 conference in Newport Beach.
Reported by Christian B.